Diabetes News and Research

Latest Diabetes News and Research

GLUMETZA patent infringement lawsuit against Lupin

Depomed, Inc. today announced that it has filed a lawsuit in the United States District Court for the Northern District of California against Lupin Limited and its wholly-owned subsidiary, Lupin Pharmaceuticals, Inc., for infringement of the patents listed in the Orange Book for GLUMETZA® (metformin hydrochloride extended release tablets).

30 Nov 2009

Pharmacists could play important role in reform

Pharmacists may play an important role in the health care system by filling in health care gaps and advising patients, according to a series of articles in The Los Angeles Times, which reports on one clinical pharmacist Steven Chen and the "Patient Safety and Clinical Pharmacy Services Collaborative, a national project under the Health Resources and Services Administration that is working to integrate clinical pharmacy services into the care of patients with chronic diseases.

30 Nov 2009

Bayer Healthcare Pharmaceuticals commences enrollment in florbetaben Phase III clinical trials

Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an international Phase III clinical trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection of beta-Amyloid plaques in the brain, which are a pathological hallmark of Alzheimer's disease.

30 Nov 2009

Eli Lilly's Cymbalta receives FDA approval

The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder (GAD) in adults, announced Eli Lilly and Company (NYSE: LLY).

30 Nov 2009

European Commission approves MICARDIS medication for CV protection

MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.

27 Nov 2009

Researchers predict diabetes cases to double and cost to triple in the next 25 years

The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.

27 Nov 2009

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic cancers.

27 Nov 2009

Experts say vitamin D assists body's immune system to fight against H1N1

The world's leading vitamin D experts say that raising your levels of "the sunshine vitamin" this winter might be the best way to help your body naturally raise its resistance to all forms of the flu virus - including the H1N1 swine flu virus.

26 Nov 2009

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

MICARDIS(R) (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor.

26 Nov 2009

Melvin R. Kaplan to be honored for his lifetime devotion to the care of patients

Melvin R. Kaplan, MD, FACP, a former Board Chair and one of the founders of the research institute that became Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), will be honored by the American College of Physicians for his lifetime devotion to the care of patients.

26 Nov 2009

Wnt signaling pathway plays a role in diabetic retinopathy

A group led by Dr. Jian-xing Ma at The University of Oklahoma Health Sciences Center, Oklahoma City, OK has demonstrated that the Wnt signaling pathway plays a role in diabetic retinopathy.

26 Nov 2009

GIS scientists publish the first genetic historical map of Han Chinese

The first genetic historical map of the Han Chinese, the largest ethnic population in the world, as they migrated from south to north over evolutionary time was published online today by the American Journal of Human Genetics by scientists at the Genome Institute of Singapore (GIS).

26 Nov 2009

Aetna Better Health teams up with Hartford student to highlight the importance of diabetes and health literacy

For the second time this year, Aetna Better Health in Connecticut is teaming up with a local student to help complete a senior year “Social Justice Project,” while at the same time informing local residents on the important issues of diabetes and health literacy.

26 Nov 2009

Preventative care program to educate and seek affordable health care for people with bipolar disorder

Once again, the National Bipolar Foundation and the MedicAlert Foundation receive a proclamation endorsing their "Safe 'til Stable" program, which is now being widely accepted as a preventive health care measure for bipolar disorder.

26 Nov 2009

Study reveals that ghrelin can increase resistance to Parkinson's disease

Ghrelin, a hormone produced in the stomach, may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in a recent issue of the Journal of Neuroscience.

25 Nov 2009

Foot ulcers: One of the many challenges of diabetics

Diabetics face many health challenges, and among them is the risk of developing foot ulcers.

25 Nov 2009

Health reform financing ideas watered down, questions remain on premiums, taxes

The New York Times reports that while the Senate health bill "includes nearly every big idea that health economists and medical researchers have for slowing cost growth — as well as for improving the patchwork quality of American health care, ... many of the ideas, like the rule on Medicare reimbursement, have been at least partly neutered. A provision to punish hospitals for infecting their patients, for example, would cut payments for the related treatments by a mere 1 percent.

25 Nov 2009

Roche's xCELLigence RTCA DP Instrument with CIM-Plate 16 enables real-time monitoring of cell migration

Cell migration is an important process in the development of organisms, as well as during immune surveillance and wound healing. For cancer development, the potential of cells to migrate or to grow invasively is, in addition to proliferation, the most important disease-causing factor. The inhibition of cell migration is a key target of the new anti-inflammatory therapies.

25 Nov 2009

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced that three new studies demonstrate that PillCam® SB endoscopy has a clear impact on how physicians manage GI patients, including those patients suspected of having Crohn's disease. The studies were presented at the Gastro 2009 conference taking place in London from November 21 to 25.

25 Nov 2009

Human Genome Sciences submits BLA for ZALBIN

Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN™ (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission includes the results of two pivotal Phase 3 clinical trials showing that 900-mcg albinterferon alfa-2b dosed every two weeks met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) dosed once each week.

25 Nov 2009

Diabetes News and Research

Latest Diabetes News and Research

GLUMETZA patent infringement lawsuit against Lupin

Pharmacists could play important role in reform

Bayer Healthcare Pharmaceuticals commences enrollment in florbetaben Phase III clinical trials

Eli Lilly's Cymbalta receives FDA approval

European Commission approves MICARDIS medication for CV protection

Researchers predict diabetes cases to double and cost to triple in the next 25 years

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

Experts say vitamin D assists body's immune system to fight against H1N1

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

Melvin R. Kaplan to be honored for his lifetime devotion to the care of patients

Wnt signaling pathway plays a role in diabetic retinopathy

GIS scientists publish the first genetic historical map of Han Chinese

Aetna Better Health teams up with Hartford student to highlight the importance of diabetes and health literacy

Preventative care program to educate and seek affordable health care for people with bipolar disorder

Study reveals that ghrelin can increase resistance to Parkinson's disease

Foot ulcers: One of the many challenges of diabetics

Health reform financing ideas watered down, questions remain on premiums, taxes

Roche's xCELLigence RTCA DP Instrument with CIM-Plate 16 enables real-time monitoring of cell migration

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Human Genome Sciences submits BLA for ZALBIN

Forensics and toxicology - Industry Focus eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Diabetes News and Research

Latest Diabetes News and Research

Forensics and toxicology - Industry Focus eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in